Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
Bayhorse Silver: Significant Scandium Values (Up to 26 G/T Sc) Accompany High Grade Silver, Bayhorse Mine, Oregon, USA
miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease
Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Fragile X Syndrome
Nevada Exploration’s Infill Borehole Program Defines Large Carlin-type Gold Deposit Target at South Grass Valley on Cortez Trend
BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema
Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting
Solid Biosciences Announces Clinical Hold On SGT-001 Phase I/II Clinical Trial For Duchenne Muscular Dystrophy
Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Brixton Metals Drills 6.7m of 937.3 g/t AgEq and 3.0m of 0.25% CoEq at its Hudson Bay Project in the Cobalt Camp, Ontario
Hiku and Jackman Reinvents Enter into Strategic Collaboration to Bring Best in Class Retail Experience to Cannabis
Cogentix Medical Faces Potential Legal Investigations Following Intended Acquisition by Laborie Medical
Biogen Announces Voluntary Drug Withdrawal and Pfizer Drug Acquisition Weeks Apart, Share Price Remains Steady
Silver Bull Intersects 10 Meters of Sulfide Mineralization Grading 347 g/t Silver, 20.7 Percent Zinc, 1.35 Percent Lead and 1.25 Percent Copper